Hawkins (HWKN) Projected to Release Quarterly Earnings on Wednesday

Hawkins (NASDAQ:HWKN) is projected to release its Q1 2027 results after the market closes on Wednesday, July 29th. Analysts expect Hawkins to announce earnings of $1.41 per share and revenue of $313.4220 million for the quarter. Investors may visit the the company’s upcoming Q1 2027 earning report for the latest details on the call scheduled for Wednesday, July 29, 2026 at 4:10 PM ET.

Hawkins (NASDAQ:HWKN) last posted its quarterly earnings data on Wednesday, May 13th. The specialty chemicals company reported $0.74 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.02). The company had revenue of $265.91 million for the quarter, compared to analysts’ expectations of $255.28 million. Hawkins had a return on equity of 16.08% and a net margin of 7.53%. On average, analysts expect Hawkins to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Hawkins Stock Performance

Shares of HWKN stock opened at $143.84 on Wednesday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.46 and a current ratio of 2.21. The firm has a market cap of $3.01 billion, a price-to-earnings ratio of 36.79, a P/E/G ratio of 2.62 and a beta of 0.78. Hawkins has a 52 week low of $117.98 and a 52 week high of $186.15. The firm’s 50-day simple moving average is $151.45 and its two-hundred day simple moving average is $150.61.

Hawkins Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 12th. Stockholders of record on Friday, May 29th were paid a dividend of $0.19 per share. The ex-dividend date was Friday, May 29th. This represents a $0.76 annualized dividend and a dividend yield of 0.5%. Hawkins’s dividend payout ratio (DPR) is presently 19.44%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on HWKN shares. Barclays set a $170.00 price target on shares of Hawkins and gave the stock an “equal weight” rating in a report on Tuesday, June 30th. Weiss Ratings lowered Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, July 14th. One investment analyst has rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $185.00.

Institutional Investors Weigh In On Hawkins

Several institutional investors have recently added to or reduced their stakes in the business. Tower Research Capital LLC TRC boosted its position in Hawkins by 605.1% during the second quarter. Tower Research Capital LLC TRC now owns 2,073 shares of the specialty chemicals company’s stock worth $295,000 after purchasing an additional 1,779 shares during the period. Empowered Funds LLC increased its stake in shares of Hawkins by 18.4% in the fourth quarter. Empowered Funds LLC now owns 2,072 shares of the specialty chemicals company’s stock worth $294,000 after purchasing an additional 322 shares in the last quarter. Freestone Grove Partners LP bought a new stake in shares of Hawkins in the fourth quarter valued at approximately $276,000. Mackenzie Financial Corp bought a new stake in shares of Hawkins in the third quarter valued at approximately $232,000. Finally, Brown Advisory Inc. purchased a new stake in shares of Hawkins during the 2nd quarter valued at approximately $225,000. 69.71% of the stock is owned by hedge funds and other institutional investors.

Hawkins Company Profile

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.